Isofol Medical AB (publ) publishes year-end report, January – December 2023
GOTHENBURG, Sweden, February 20, 2024 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company’s year-end report […]
English
Isofol’s Board of Directors decides to initiate the planning of clinical studies and will announce a strategic development plan on March 19
GOTHENBURG, Sweden, February 14, 2024 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), has been engaged in intensive strategy work
Isofol appoints Magnus Hurst as new Chief Financial Officer
GOTHENBURG, Sweden, January 10, 2024 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the company has appointed
Isofol appoints Petter Segelman Lindqvist as new CEO
GOTHENBURG, Sweden, January 9, 2024 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company’s Board of
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on January 4, 2024
Today on January 4, 2024 in Gothenburg, Sweden – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), held its extraordinary general
Isofol presents additional results from laboratory tests with arfolitixorin showing supplementary effects
GOTHENBURG, Sweden, December 28, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company has received
Isofol’s board of directors announces its position on minority shareholder’s proposal ahead of extraordinary general meeting
GOTHENBURG, Sweden, December 13, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that all of the company’s
Isofol has received the first results from laboratory tests of arfolitixorin
GOTHENBURG, Sweden, December 7, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company has received
Isofol is liquidating a subsidiary
GOTHENBURG, Sweden, December 1, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the subsidiary Isofol Medical
Notice convening the Extraordinary General Meeting in Isofol Medical AB (publ) 4 January 2024
GOTHENBURG, Sweden, November 21, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), hereby invites the shareholders of Isofol Medical